Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of i.v. Bisphosphonate on Health-Related Quality of Life and Skeletal Morbidity for Newly Diagnosed Treatment Demanding Multiple Myeloma. A Prospective Randomised Double Blinded Dose-Effective Study With Cost-Utility Analysis.

NCT00376883 is registered in ClinicalTrials.gov with Nordic Myeloma Study Group as lead sponsor.

NCT NCT00376883
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00376883 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of i.v. Bisphosphonate on Health-Related Quality of Life and Skeletal Morbidity for Newly Diagnosed Treatment Demanding Multiple Myeloma. A Prospective Randomised Double Blinded Dose-Effective Study With Cost-Utility Analysis.
Lead sponsor
Nordic Myeloma Study Group
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2000
Completion date
October 31, 2006
Enrollment
500
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma